Live Breaking News & Updates on Regulatory At Ovid Therapeutics Inc

Stay updated with breaking news from Regulatory at ovid therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Gain Therapeutics Announcements | Gain Therapeutics: Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors

Gain Therapeutics
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (“Gain”) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board. ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Silverstein Foundation For Parkinson , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,

Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors

(2)
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. ( Gain ) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board.
We are pleased to welcome such a distinguished group of board members at this pivotal time for Gain, said Eric Richman, Chief Executive Officer at Gain. Their decades of experience across the biopharmaceutical industry will be invaluable as we continue to advance our pipeline and determine how our proprietary Site-Directed Enzyme Enhancement Th ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Kostenloser Wertpapierhandel , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,